Details
Stereochemistry | RACEMIC |
Molecular Formula | C14H20N2O2.ClH |
Molecular Weight | 284.782 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(C)(C)NCC(O)COC1=C(C=CC=C1)C#N
InChI
InChIKey=RJPWESHPIMRNNM-UHFFFAOYSA-N
InChI=1S/C14H20N2O2.ClH/c1-14(2,3)16-9-12(17)10-18-13-7-5-4-6-11(13)8-15;/h4-7,12,16-17H,9-10H2,1-3H3;1H
Bunitrolol is a beta-adrenergic antagonist that can be used for treatment of coronary heart disease. It improves cardiac performance after beta-blockade in patients with coronary artery disease. Bunitrolol was found to have a greater beta 1 than beta 2 adrenergic activity and a weak alpha 1 blocking action.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P08588 Gene ID: 153.0 Gene Symbol: ADRB1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/2570175 |
42.0 nM [Ki] | ||
Target ID: P07550|||Q53GA6|||Q9UCZ3 Gene ID: 154.0 Gene Symbol: ADRB2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/2570175 |
3.55 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Plasma catecholamines, plasma renin activity and haemodynamics during sodium nitroprusside-induced hypotension and additional beta-blockage with bunitrolol. | 1981 |
|
Functional evaluation of cytochrome P450 2D6 with Gly42Arg substitution expressed in Saccharomyces cerevisiae. | 2001 Nov |
|
CYP2D-related metabolism in animals of the Canoidea superfamily - species differences. | 2006 Jul |
|
Extrapolating in vitro metabolic interactions to isolated perfused liver: predictions of metabolic interactions between R-bufuralol, bunitrolol, and debrisoquine. | 2010 Oct |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18374
Bunitrolol 10 mg administered to patients with coronary artery disease
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2893855
For assessments of pharmacological activities of bunitrolol the guinea pig trachea, left and right atria and aorta, and the rat aorta were used. Dose-response curves were obtained in the absence or presence of bunitrolol of the following concentrations: trachea, left and right atria 10(-8) M, guinea pig aorta 10(-4) M; rat aorta, 3x10(-6) M.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID80945768
Created by
admin on Fri Dec 15 17:10:54 GMT 2023 , Edited by admin on Fri Dec 15 17:10:54 GMT 2023
|
PRIMARY | |||
|
m2763
Created by
admin on Fri Dec 15 17:10:54 GMT 2023 , Edited by admin on Fri Dec 15 17:10:54 GMT 2023
|
PRIMARY | |||
|
29876-08-2
Created by
admin on Fri Dec 15 17:10:54 GMT 2023 , Edited by admin on Fri Dec 15 17:10:54 GMT 2023
|
PRIMARY | |||
|
CHEMBL418134
Created by
admin on Fri Dec 15 17:10:54 GMT 2023 , Edited by admin on Fri Dec 15 17:10:54 GMT 2023
|
PRIMARY | |||
|
31641
Created by
admin on Fri Dec 15 17:10:54 GMT 2023 , Edited by admin on Fri Dec 15 17:10:54 GMT 2023
|
PRIMARY | |||
|
245-427-5
Created by
admin on Fri Dec 15 17:10:54 GMT 2023 , Edited by admin on Fri Dec 15 17:10:54 GMT 2023
|
PRIMARY | |||
|
23093-74-5
Created by
admin on Fri Dec 15 17:10:54 GMT 2023 , Edited by admin on Fri Dec 15 17:10:54 GMT 2023
|
SUPERSEDED | |||
|
100000084854
Created by
admin on Fri Dec 15 17:10:54 GMT 2023 , Edited by admin on Fri Dec 15 17:10:54 GMT 2023
|
PRIMARY | |||
|
SUB00900MIG
Created by
admin on Fri Dec 15 17:10:54 GMT 2023 , Edited by admin on Fri Dec 15 17:10:54 GMT 2023
|
PRIMARY | |||
|
A42VUS2X73
Created by
admin on Fri Dec 15 17:10:54 GMT 2023 , Edited by admin on Fri Dec 15 17:10:54 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD